Postmenopausal Osteoporosis

Overview

Journal Curr Opin Endocrinol Diabetes Obes

Specialty Endocrinology

Date 2013 Oct 24

PMID 24150190

Citations 39

Authors

Dima L Diab

Nelson B Watts

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: The aim of this study is to provide a thorough updated review of the diagnosis and treatment of postmenopausal osteoporosis.

Recent Findings: There have been several important findings in the field of postmenopausal osteoporosis over the past 1-2 years. Fewer morphometric vertebral fractures were found in women treated for 6 years with zoledronic acid compared with those who stopped treatment after 3 years. Longer duration of bisphosphonate therapy is associated with a higher risk of atypical femur fractures. Combination therapy with teriparatide and denosumab appears to increase bone mineral density to a greater extent than either therapy alone in postmenopausal women at high risk for fracture. There are several novel therapies under investigation for the treatment of osteoporosis, which are in various stages of development. Nonadherence to osteoporosis therapies continues to be a major problem in clinical practice.

Summary: There are numerous effective pharmacologic treatment options for postmenopausal osteoporosis. Bisphosphonate drug holidays continue to be an area of significant debate.

Citing Articles

Total flavonoids isolated from can alleviate bone loss and regulate intestinal microbiota in ovariectomized rats.

Yin B, Yang M, Wang B, Zhang Y, Li N, Li Q Front Pharmacol. 2025; 16:1513863.

PMID: 39989899 PMC: 11842935. DOI: 10.3389/fphar.2025.1513863.

Pregnancy and Lactation Associated Osteoporosis in a 24-Year-Old Presenting with Multiple Fragility Fractures in the Dorsolumbar Spine: A Case Report and Review of Literature.

Gandhi T, Bhilare P, Sancheti P J Orthop Case Rep. 2024; 14(11):129-134.

PMID: 39524290 PMC: 11546015. DOI: 10.13107/jocr.2024.v14.i11.4940.

Osteoblast-specific down-regulation of NLRP3 inflammasome by aptamer-functionalized liposome nanoparticles improves bone quality in postmenopausal osteoporosis rats.

Xu L, Zhu J, Rong L, Yang H, Wang B, Lu S Theranostics. 2024; 14(10):3945-3962.

PMID: 38994035 PMC: 11234270. DOI: 10.7150/thno.95423.

Increased Potential of Bone Formation with the Intravenous Injection of a Parathyroid Hormone-Related Protein Minicircle DNA Vector.

Kim J, Park N, Kang J, Kim Y, Jung H, Rim Y Int J Mol Sci. 2021; 22(16).

PMID: 34445802 PMC: 8396456. DOI: 10.3390/ijms22169069.

Beraprost ameliorates postmenopausal osteoporosis by regulating Nedd4-induced Runx2 ubiquitination.

Zheng H, Xu W, Zhou W, Yang R, Chen P, Liu T Cell Death Dis. 2021; 12(5):497.

PMID: 33993186 PMC: 8124066. DOI: 10.1038/s41419-021-03784-8.